fbpx
Medical Innovation Exchange

Gilmore O'Neill picked a bad time to become a biotech CEO. He's confident Editas has the goods

https://www.fiercebiotech.com/biotech/editas-new-ceo-gilmore-oneill-talks-crispr-priorities-baisong-mei-fills-cmo-role-gene

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.